Clinical trial
Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative…
NCT00420563 · Centre Oscar Lambret, Other · Completed
Key facts
| NCT number | NCT00420563 |
|---|---|
| Title | Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer |
| Official title | A Phase II Randomized Study to Assess the Benefit of a Metronomic Chemotherapy by Cyclophosphamide Versus Megestrol in Palliative Cancer |
| Acronym | PALANGI-0601 |
| Lead sponsor | Centre Oscar Lambret, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Cancer |
| Intervention type | Drug |
| Interventions | CYCLOPHOSPHAMIDE, MEGESTROL |
| Enrollment | 88 |
| Start date | Sep 1, 2006 |
| Primary completion | Jan 1, 2009 |
| Completion | Jul 1, 2009 |
| First posted | Jan 11, 2007 |
| Last update posted | Jul 23, 2012 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: